England’s biotech startup Sitryx out of the blocks with new I/O program. Stakes are high as Europe’s science contending with US for top global developers.

The News: Sitryx Therapeutics Ltd. (London) has launched with the goal of treating cancer and inflammatory conditions by targeting the metabolism of immune cells, a promising new area of research…. Read more »

PART TWO: The future of Russian pharma. Why does China (among so many others) surpass Russia when it comes to pharma/biotech innovation?

In examining why Russia is behind its neighbor China in pharma and biotech innovation, one must keep in mind that Chinese medicine is a style of traditional treatment built on a foundation… Read more »

FDA clears psilocybin for testing as breakthrough therapy

UPDATE: FDA permits psilocybin to be tested for refractory depression; grants Breakthrough Therapy designation for magic mushrooms psychedelic compound. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy… Read more »

Europe bursts onto the biotech scene as Grifols’ Phase 2b/3 plasma replacement therapy works in Alzheimer’s patients. Buy, sell or hold?

The News: A blood plasma replacement therapy from Spanish company Grifols SA (Barcelona) reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo, Labiotech.eu reports. The… Read more »

October wraps up healthcare IPOs with another strong week as 2018 biotech explosion still on record pace.

The News: The Wall Street Journal reports that the pace of biotech IPOs in on track for a near-record year, although many are riskier due to being in earlier stages of development…. Read more »

Stodgy Johns Hopkins wants FDA to clear psilocybin mushrooms for depression. Here’s what you need to know (or recall) about the differences between magic shrooms and, say, LSD.

The News: Researchers from Johns Hopkins University (Baltimore) have recommended that psilocybin, the active compound in hallucinogenic mushrooms, be reclassified for medical use, potentially paving the way for the psychedelic… Read more »

Atrial fibrillation increases risk of dementia by 40%, Swedish study shows. Bring on those blood thinners, say researchers.

The News: New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. An irregular heartbeat speeds up the… Read more »

Physician burnout taking center stage; what patients should know as burnout percentage soars.

The News: Nearly half of medical residents report burnout during their second year of residency, and 1 in 7 report regretting their career choice, according to a prospective study published online last… Read more »